GPO-VIR Z 250
2045
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection

2045
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection
